Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm

Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: کامران شادور , علی تقی زادیه , علی اکبر قمری , حسن سلیمانپور , عطا محمودپور

کلمات کلیدی: Hemoperfusion,Treatment,Critically,COVID-19,Cytokine Storm

نشریه: 4920 , 3 , 50 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله عطا محمودپور
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده پزشکی
کد مقاله 74435
عنوان فارسی مقاله Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm
عنوان لاتین مقاله Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm
ناشر 5
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Letter to Editor
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

After COVID-19 outbreak in China in late 2019 and change to pandemic in early 2020, the disease became a clinical threat to the whole world [1]. Urgent clinical guidance for intensive management of critically ill pa-tients is needed. To date, therapeutic options for severe COVID-19 remain limited, and this disease has high mortality in patients admitted to intensive care units (ICUs) [2]. Huang et al. [5] reported the clinical features and cytokine profile of critically ill patients with COV-ID-19 in Wuhan, China, and suggested that a cytokine storm had a high mortality rate and was a leading cause of organ dysfunction and death in these patients. Infec-tious and noninfectious triggers can result in a cytokine storm, progressing to vasoplegic shock and finally multi-organ dysfunction syndrome (MODS) [3]. Early detec-tion and appropriate management of this storm can be an important intervention in decreasing the mortality of critically ill COVID-19 patients. From the first admission of critically ill COVID-19 patients in our ICU on March 10, 2020, we had 8 cases of hemoperfusion in our patients. Our standard treatment protocol beside antiviral therapy for these patients included using HFNC/noninvasive ventilation (Helmet) based on availability as the first choice in patients with acute respiratory failure. If pa-tients failed these interventions and were awake and co-operative, we would try early application of prone posi-tioning (cooperative prone positioning) with noninvasive ventilation/HFNC as long as they tolerate. If the situation went wrong, we would try intubation and mechanical ventilation with lung protective strategy (tidal volume of 4–6 mL/predicted body weight and adjustment of it based on driving pressure of 14 cm H2O and plateau pressure of 30 cm H2O). PEEP was adjusted and titrated based on stress index and driving pressure. However, if increasing PEEP resulted in improved oxygenation, we would in-crease the PEEP number, but if increasing PEEP did not result in improving oxygenation, we would consider the patient as a nonresponder and would not increase PEEP to more than 12 cm H2O. We used adjunctive therapies in patients with cytokine storm without considering the method of ventilation. If the patient had at least 2 of the criteria in Figure 1, the situation would be considered as cytokine storm. Cytokine storm was diagnosed in 8 pa-tients; 4 of them were nonintubated. One patient received 4 sessions of hemoperfusion, and 1 patient received just 2 sessions as he died before the third session

نویسندگان
hide/show

نویسنده نفر چندم مقاله
کامران شادوراول
علی تقی زادیهدوم
علی اکبر قمریسوم
حسن سلیمانپورچهارم
عطا محمودپورپنجم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
hemoperfusion.pdf1399/08/25159403دانلود
91140273.pdf1400/08/22483451دانلود
91143186.pdf1400/08/23509588دانلود